Max Chaffanet Selected Research

Neoplasm Metastasis (Metastasis)

4/2022	Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.
2/2019	Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.
5/2016	Comparative genomic analysis of primary tumors and metastases in breast cancer.
11/2014	Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
8/2014	ESPL1 is a candidate oncogene of luminal B breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Max Chaffanet Research Topics

Disease

36	Neoplasms (Cancer) 07/2023 - 09/2005
22	Breast Neoplasms (Breast Cancer) 07/2023 - 08/2003
5	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2014
3	Triple Negative Breast Neoplasms 01/2023 - 12/2019
2	Carcinoma (Carcinomatosis) 01/2022 - 12/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2018
2	Carcinogenesis 11/2014 - 03/2011
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2007 - 01/2003
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2023
1	Urologic Neoplasms (Urological Cancer) 05/2022
1	Endometrial Neoplasms (Endometrial Cancer) 04/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Pancreatoblastoma 01/2021
1	Brain Neoplasms (Brain Tumor) 05/2019
1	Inflammatory Breast Neoplasms 01/2017
1	Chromosomal Instability (Chromosome Stability) 08/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2014
1	Adenocarcinoma 06/2011
1	Glioma (Gliomas) 09/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2003
1	Genetic Translocation (Chromosomal Translocation) 01/2003

Drug/Important Bio-Agent (IBA)

14	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 08/2006
9	Phenobarbital (Luminal)FDA Link 07/2023 - 12/2007
6	Messenger RNA (mRNA)IBA 07/2023 - 08/2010
6	Hormones (Hormone)IBA 04/2022 - 03/2011
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
3	Estrogen ReceptorsIBA 10/2014 - 10/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2010 - 01/2003
3	Phosphotransferases (Kinase)IBA 02/2008 - 01/2003
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 09/2005
2	Antisense OligonucleotidesIBA 07/2023 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 12/2021
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2022 - 12/2021
2	amitraz (Taktic)IBA 01/2022 - 12/2021
2	Circulating Tumor DNAIBA 01/2022 - 01/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 10/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2018 - 05/2011
2	Myristoylated Alanine-Rich C Kinase SubstrateIBA 12/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2014 - 06/2011
2	OligonucleotidesIBA 02/2008 - 12/2007
1	EuchromatinIBA 11/2023
1	ChromatinIBA 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 07/2023
1	olaparibIBA 01/2023
1	enfortumab vedotinIBA 01/2022
1	HSP27 Heat-Shock ProteinsIBA 01/2022
1	taxaneIBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	monomethyl auristatin EIBA 01/2022
1	tariquidar (XR9576)IBA 01/2022
1	NectinsIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2022
1	CateninsIBA 01/2021
1	folfirinoxIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	Cetuximab (Erbitux)FDA Link 12/2019
1	Trastuzumab (Herceptin)FDA Link 02/2019
1	P-2 (P 2)IBA 02/2019
1	LipidsIBA 11/2015
1	Nucleic AcidsIBA 11/2015
1	LigandsIBA 03/2015
1	ClaudinsIBA 10/2014
1	SeparaseIBA 08/2014
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2011
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2010
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2008
1	Protein Kinases (Protein Kinase)IBA 02/2008
1	Tyrosine (L-Tyrosine)FDA Link 03/2007
1	ParaffinIBA 10/2004
1	Neuregulin-1 (Neuregulin 1)IBA 10/2004
1	fragile histidine triad proteinIBA 12/2003
1	NeuregulinsIBA 08/2003
1	Dacarbazine (DIC)FDA LinkGeneric 08/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2003

Therapy/Procedure

11	Therapeutics 05/2022 - 03/2011
3	Drug Therapy (Chemotherapy) 01/2023 - 12/2021
3	Precision Medicine 05/2022 - 05/2016
2	Neoadjuvant Therapy 01/2023 - 02/2019
1	Castration 01/2022
1	Adjuvant Chemotherapy 08/2014
1	Lasers (Laser) 03/2014